NCT05826145

Brief Summary

To provide a palliative bereavement support program for caregivers to decrease the risk for developing complicated and persistent grief.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 9, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

April 24, 2023

Status Verified

April 1, 2023

Enrollment Period

2 years

First QC Date

April 9, 2023

Last Update Submit

April 21, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Bereavement Experience Questionnaire (BEQ-24) from Baseline

    Short form of 24 questions consisting of three subscales of 1) Existential Loss/Emotional Needs, 2) Guilt/Blame/Anger, and 3) Preoccupation with Thoughts of Deceased.

    3 months

  • Change in Bereavement Experience Questionnaire (BEQ-24) from Baseline

    Short form of 24 questions consisting of three subscales of 1) Existential Loss/Emotional Needs, 2) Guilt/Blame/Anger, and 3) Preoccupation with Thoughts of Deceased.

    6 months

Secondary Outcomes (2)

  • Change in Patient Health Questionnaire-9 from Baseline

    3 months

  • Change in Patient Health Questionnaire-9 from Baseline

    6 months

Study Arms (2)

Vocal Expression

ACTIVE COMPARATOR

Supportive care through vocal expression sessions where participants can talk for approximately 20-30 minutes about the person who died.

Behavioral: Vocal Expression

Cognitive Behavioral

EXPERIMENTAL

Cognitive-behavioral techniques with sessions consisting of approximately 20-30 minutes.

Behavioral: Cognitive Behavioral

Interventions

There will be a total of 8 sessions. At baseline (week 0), only questionnaires will be completed. There will be 7 treatment sessions beginning at week 2, and the other sessions conducted at approximately every 3 weeks over the 6-month study duration where the vocal expression sessions will be provided.

Vocal Expression

There will be 8 treatment sessions where part of the baseline session of session 1 (week 0) will include some instruction, session 2 will occur in week 2, and the other sessions conducted at approximately every 3 weeks over the 6-month study duration. Sessions will include various cognitive-behavioral techniques including completing a grief monitoring diary, imaginal revisiting, cognitive restructuring, describing positive memories of the deceased, and identifying future goals.

Cognitive Behavioral

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informal family (or friend) caregivers, who are 18 years and older, who are caring for patients 18 years and older.
  • Patient location may include the emergency department, or inpatient settings when patients are referred to Palliative Care services for end-of-life care.
  • Caregivers for patients who die at the hospital are included in this study.
  • Only will include those who speak English.

You may not qualify if:

  • Caregivers or patients under the age of 18.
  • Pregnant caregivers.
  • Court appointed guardians.
  • Caregivers who have history of psychiatric illness, high depression scores on the PHQ-9 (\>20), suicidal ideation, or anxiety symptoms of panic attacks on initial screening will not be included and will be provided contact information to obtain treatment at Behavioral Health.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

South Brooklyn Health

Brooklyn, New York, 11235, United States

Location

Study Officials

  • Marina Ivanyuk, MD

    New York City Health and Hospitals Corporation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marina Ivanyuk, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The control group will receive supportive care through vocal expression sessions. The treatment group will receive supportive care through cognitive-behavioral techniques.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Palliative Care

Study Record Dates

First Submitted

April 9, 2023

First Posted

April 24, 2023

Study Start

April 1, 2023

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

April 24, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

We do not plan to share individual participant data with other researchers.

Locations